Lonza cleared to acquire Capsugel in $5.5 billion deal
June 28, 2017Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition
Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …
Gold rods used to ‘break cancer’s legs’
June 28, 2017Research and Development Cancer, Georgia Tech, nanorods
A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …
MSD struck in second global cyber attack
June 28, 2017Medical Communications, Research and Development Cyber attack, MSD
Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …
Revolutionary patch could offer alternative to flu injections
June 28, 2017Research and Development flu, flu vaccine, patch delivery
A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …
FDA weighs in to improve generic competition
June 27, 2017Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate
Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …
Novo Nordisk’s diabetes drug recommended for expanded indication in Europe
June 27, 2017Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …
New potential blockbuster RA treatment enters European market
June 27, 2017Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi
The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …
Biogen appoint new Head of Global Therapeutic Operations
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress
Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
UK launch of two Novartis biosimilars could cut NHS costs
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab
Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
Number of patients at risk from NHS mail mistake revealed
June 27, 2017Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England
According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
Duchenne drug made available to UK patients early
June 27, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone
UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …
The July/August 2017 issue of Pharmafocus is now live!
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus
The July/August edition of Pharmafocus is now available – click here to read online.
Therapy able to block both opioid high and withdrawal
June 26, 2017Manufacturing and Production, Research and Development Camurus, buprenorphine
A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …
Drug Combinations and Emerging Interactions
June 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature
Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …
Humira set to face new European biosimilar rival
June 26, 2017Sales and Marketing CHMP, EMA, Samsung Bioepis
A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …
Roche haemophilia therapy cuts bleed rate by 87%
June 26, 2017Research and Development, Sales and Marketing Roche, haemophilia
Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …
Public dissatisfaction with NHS found to be growing, says BMA
June 26, 2017Medical Communications, Sales and Marketing BMA, NHS
The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …
Promising Phase 2 obesity data for Novo’s diabetes drug
June 26, 2017Research and Development, Sales and Marketing Novo Nordisk
Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …
Astellas receives further year suspension from ABPI
June 26, 2017Medical Communications, Sales and Marketing ABPI, Astellas
The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
